Merck Healthcare – a platinum sponsor of the Joint Congress of ESPE and ESE 2025.
Merck, a leading science and technology company, operates across healthcare, life science and electronics.
Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices. The company is everywhere.
In 2023 Merck generated sales of € 21.0 billion in 65 countries.
Find us on booth 41 in the exhibition hall E.
All further details below will be available on the Congress webpage too.
Congress activities
Monday 12 May 2025, Room D2
Continuum of Care in Growth Hormone Therapy. A Merck Healthcare sponsored satellite symposium.
Chair: Dr. Agnès Linglart, France
The Role of Digital Health in Growth Hormone Therapy: Insights from a Comparative Longitudinal Study
Dr. Antonio de Arriba Muñoz, Spain
From Data to Diagnosis: Using AI, Machine Learning, and EMR Data to Manage Adult Growth Hormone Deficiency
Dr. Edoardo Vergani, Italy
Growth Hormone Replacement Therapy in Heart Failure with Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial
Dr. Antonio Cittadini, Italy
Sunday, 11. May 2025, Room D2
Health Economic Insights in growth hormone disorders: From Principles to Practice. A Merck Healthcare sponsored satellite symposium.
Chair: Prof. Paul Dimitri, UK
Health Economic Insights in Growth Hormone Disorders: From Principles to Practice
Jorge Félix, Portugal
